Isoliquiritigenin Induces Mitochondrial Dysfunction and Apoptosis by Inhibiting mitoNEET in a Reactive Oxygen Species-Dependent Manner in A375 Human Melanoma Cells

Area of Science:

• Biochemistry
• Cell Biology
• Molecular Medicine

Background:

• MitoNEET, an iron-sulfur protein on the mitochondrial outer membrane, is implicated in various human diseases.
• Dysregulation of mitoNEET is linked to pathologies such as diabetes and neurodegeneration.

Purpose of the Study:

• To investigate the effect of isoliquiritigenin (ISL) on mitoNEET expression in A375 melanoma cells.
• To elucidate the role of mitoNEET in ISL-induced cellular responses, including reactive oxygen species (ROS) production, mitochondrial dysfunction, and apoptosis.

Main Methods:

• Quantitative analysis of mitoNEET expression in A375 melanoma cells treated with ISL.
• Assessment of cellular ROS content and mitochondrial membrane potential.
• Evaluation of apoptosis rates in ISL-treated cells with varying mitoNEET expression levels.

Main Results:

• Isoliquiritigenin (ISL) significantly decreased mitoNEET expression in A375 melanoma cells.
• ISL treatment increased cellular ROS content, an effect that was attenuated by mitoNEET overexpression.
• Overexpression of mitoNEET mitigated the ISL-induced increase in apoptosis and decrease in mitochondrial membrane potential.

Conclusions:

• ISL reduces mitoNEET expression, leading to altered ROS levels, mitochondrial dysfunction, and apoptosis in A375 melanoma cells.
• These findings establish mitoNEET as a key regulator in ISL's anti-cancer effects and highlight its potential as a therapeutic target in cancer treatment.